Spots Global Cancer Trial Database for folfiri regimen
Every month we try and update this database with for folfiri regimen cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Combination Chemotherapy in Treating Patients With Unresectable Metastatic Colorectal Cancer | NCT00008060 | Colorectal Canc... | FOLFIRI regimen FOLFOX regimen fluorouracil irinotecan hydr... leucovorin calc... oxaliplatin | 18 Years - | National Cancer Institute (NCI) | |
| Camrelizumab Combined With Trastuzumab and Chemotherapy in Patients With HER2-positive Advanced Colorectal Cancer | NCT05193292 | Colorectal Neop... Intestinal Neop... | Camrelizumab Trastuzumab XELOX regimen mFOLFOX6 regime... FOLFIRI regimen mXELIRI regimen mIRIS regimen | 18 Years - | Fudan University | |
| Fluorouracil and Leucovorin With or Without Irinotecan in Treating Patients Following Surgery for Stage III Colorectal Cancer | NCT00026273 | Colorectal Canc... | FOLFIRI regimen fluorouracil irinotecan hydr... leucovorin calc... | 18 Years - 75 Years | Pfizer | |
| Fluorouracil, Leucovorin, and Irinotecan in Treating Patients With Recurrent or Refractory Metastatic Unresectable Colorectal Cancer | NCT00075595 | Colorectal Canc... | FOLFIRI regimen fluorouracil irinotecan hydr... leucovorin calc... | 18 Years - 80 Years | National Cancer Institute (NCI) | |
| Combination Chemotherapy With or Without Chemoembolization in Treating Patients With Colorectal Cancer Metastatic to the Liver (6655) | NCT00023868 | Colorectal Canc... Metastatic Canc... | FOLFIRI regimen cisplatin doxorubicin hyd... fluorouracil irinotecan hydr... leucovorin calc... mitomycin C | 18 Years - 120 Years | American College of Radiology Imaging Network | |
| A Study to Investigate Ompenaclid Combined With FOLFIRI Plus Bevacizumab in Advanced/Metastatic Colorectal Cancer | NCT05983367 | Colorectal Canc... Metastatic Colo... | Ompenaclid (RGX... Placebo Bevacizumab FOLFIRI regimen | 18 Years - | Inspirna, Inc. | |
| Standard Therapy With or Without Surgery and Mitomycin C in Treating Patients With Advanced Limited Peritoneal Dissemination of Colon Cancer | NCT01167725 | Colorectal Canc... | bevacizumab cetuximab FOLFIRI regimen FOLFOX regimen capecitabine fluorouracil irinotecan hydr... leucovorin calc... mitomycin C oxaliplatin therapeutic con... | 18 Years - | National Cancer Institute (NCI) | |
| wXELIRI Versus FOLFIRI Regimen in the Treatment of Advanced Colorectal Cancer Patients | NCT01736904 | Colorectal Canc... | wXELIRI regimen FOLFIRI regimen | 18 Years - 70 Years | Fudan University | |
| Sunitinib Malate and Combination Chemotherapy as Front-Line Therapy in Treating Patients With Metastatic Rectal Cancer That Cannot Be Removed by Surgery | NCT00936832 | Colorectal Canc... Metastatic Canc... | FOLFIRI regimen fluorouracil irinotecan hydr... leucovorin calc... sunitinib malat... laboratory biom... pharmacogenomic... pharmacological... | 18 Years - 120 Years | Federation Francophone de Cancerologie Digestive | |
| A Study to Investigate Ompenaclid Combined With FOLFIRI Plus Bevacizumab in Advanced/Metastatic Colorectal Cancer | NCT05983367 | Colorectal Canc... Metastatic Colo... | Ompenaclid (RGX... Placebo Bevacizumab FOLFIRI regimen | 18 Years - | Inspirna, Inc. | |
| Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer | NCT00006115 | Colorectal Canc... | FOLFIRI regimen FOLFOX regimen fluorouracil irinotecan hydr... leucovorin calc... oxaliplatin | 18 Years - 80 Years | National Cancer Institute (NCI) | |
| Combination Chemotherapy With or Without Celecoxib in Treating Patients With Metastatic Colorectal Cancer | NCT00064181 | Colorectal Canc... | FOLFIRI regimen capecitabine celecoxib fluorouracil irinotecan hydr... leucovorin calc... | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Camrelizumab Combined With Trastuzumab and Chemotherapy in Patients With HER2-positive Advanced Colorectal Cancer | NCT05193292 | Colorectal Neop... Intestinal Neop... | Camrelizumab Trastuzumab XELOX regimen mFOLFOX6 regime... FOLFIRI regimen mXELIRI regimen mIRIS regimen | 18 Years - | Fudan University | |
| A Study of PRO95780 in Combination With Cetuximab and Irinotecan Chemotherapy or the FOLFIRI Regimen With Bevacizumab in Patients With Previously Treated Metastatic Colorectal Cancer (APM4187g) | NCT00497497 | Colorectal Canc... | bevacizumab cetuximab FOLFIRI regimen irinotecan PRO95780 | 18 Years - | Genentech, Inc. | |
| Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation | NCT06252649 | Metastatic Colo... | FOLFIRI Regimen Sotorasib Panitumumab Bevacizumab-aww... | 18 Years - | Amgen | |
| Chemotherapy With or Without Isolated Hepatic Perfusion With Melphalan in Treating Patients With Colorectal Cancer That Has Spread to the Liver | NCT00020501 | Colorectal Canc... Metastatic Canc... | FOLFIRI regimen floxuridine fluorouracil irinotecan hydr... leucovorin calc... melphalan hyperthermia tr... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Combination Chemotherapy With or Without Irinotecan in Treating Patients With Stage III Colon Cancer | NCT00005979 | Colorectal Canc... | FOLFIRI regimen fluorouracil irinotecan hydr... leucovorin calc... | 18 Years - 75 Years | UNICANCER | |
| Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Cancer of the Stomach or Esophagus | NCT00005607 | Esophageal Canc... Gastric Cancer | FOLFIRI regimen fluorouracil irinotecan hydr... leucovorin calc... | 18 Years - | National Cancer Institute (NCI) | |
| A Study Of PF-05212384 Plus FOLFIRI Versus Bevacizumab Plus FOLFIRI In Metastatic Colorectal Cancer | NCT01937715 | Metastatic Colo... | PF-05212384 FOLFIRI regimen Bevacizumab FOLFIRI | 18 Years - | Pfizer | |
| Combination Chemotherapy in Treating Patients Who Have Advanced Solid Tumors | NCT00020488 | Unspecified Adu... | FOLFIRI regimen fluorouracil irinotecan hydr... leucovorin calc... | 18 Years - | National Cancer Institute (NCI) | |
| Chemotherapy With or Without Isolated Hepatic Perfusion With Melphalan in Treating Patients With Colorectal Cancer That Has Spread to the Liver | NCT00020501 | Colorectal Canc... Metastatic Canc... | FOLFIRI regimen floxuridine fluorouracil irinotecan hydr... leucovorin calc... melphalan hyperthermia tr... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| XCHT for Irinotecan-Induced Gut Toxicities (Run-in Study) | NCT04926545 | Malignant Tumor Diarrhea | Xiao Chai Hu Ta... Raloxifene FOLFIRI regimen | 18 Years - 75 Years | Guangzhou University of Traditional Chinese Medicine | |
| Fluorouracil, Leucovorin, and Irinotecan in Treating Patients With Recurrent or Refractory Metastatic Unresectable Colorectal Cancer | NCT00075595 | Colorectal Canc... | FOLFIRI regimen fluorouracil irinotecan hydr... leucovorin calc... | 18 Years - 80 Years | National Cancer Institute (NCI) | |
| wXELIRI Versus FOLFIRI Regimen in the Treatment of Advanced Colorectal Cancer Patients | NCT01736904 | Colorectal Canc... | wXELIRI regimen FOLFIRI regimen | 18 Years - 70 Years | Fudan University | |
| Irinotecan Hydrochloride, Fluorouracil, and Leucovorin Calcium With or Without Zibotentan in Treating Patients With Metastatic Colorectal Cancer | NCT01205711 | Colorectal Canc... | FOLFIRI regimen fluorouracil irinotecan hydr... leucovorin calc... zibotentan laboratory biom... pharmacogenomic... | 18 Years - | Cardiff University | |
| Combination Chemotherapy and Bevacizumab With or Without Bevacizumab Maintenance Therapy in Treating Patients With Metastatic Colorectal Cancer | NCT00952029 | Colorectal Canc... | bevacizumab FOLFIRI regimen fluorouracil irinotecan hydr... leucovorin calc... | 18 Years - 120 Years | Federation Francophone de Cancerologie Digestive | |
| Vaccine Therapy and Chemotherapy With or Without Tetanus Toxoid Compared With Chemotherapy Alone in Treating Patients With Metastatic Colorectal Cancer | NCT00027833 | Colorectal Canc... | ALVAC-CEA-B7.1 ... tetanus toxoid FOLFIRI regimen fluorouracil irinotecan hydr... leucovorin calc... | 18 Years - | National Cancer Institute (NCI) | |
| Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation | NCT06252649 | Metastatic Colo... | FOLFIRI Regimen Sotorasib Panitumumab Bevacizumab-aww... | 18 Years - | Amgen | |
| Combination Chemotherapy in Treating Patients With Recurrent Metastatic Colorectal Cancer | NCT00003260 | Colorectal Canc... | FOLFIRI regimen FOLFOX regimen fluorouracil irinotecan hydr... leucovorin calc... oxaliplatin | 18 Years - 75 Years | National Cancer Institute (NCI) | |
| A Study to Investigate Ompenaclid Combined With FOLFIRI Plus Bevacizumab in Advanced/Metastatic Colorectal Cancer | NCT05983367 | Colorectal Canc... Metastatic Colo... | Ompenaclid (RGX... Placebo Bevacizumab FOLFIRI regimen | 18 Years - | Inspirna, Inc. | |
| Fluorouracil and Leucovorin With or Without Irinotecan in Treating Patients With Metastatic Colorectal Cancer | NCT00004885 | Colorectal Canc... | FOLFIRI regimen fluorouracil irinotecan hydr... leucovorin calc... | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Combination Chemotherapy With or Without Irinotecan in Treating Patients With Stage III Colon Cancer | NCT00005979 | Colorectal Canc... | FOLFIRI regimen fluorouracil irinotecan hydr... leucovorin calc... | 18 Years - 75 Years | UNICANCER | |
| Standard Therapy With or Without Surgery and Mitomycin C in Treating Patients With Advanced Limited Peritoneal Dissemination of Colon Cancer | NCT01167725 | Colorectal Canc... | bevacizumab cetuximab FOLFIRI regimen FOLFOX regimen capecitabine fluorouracil irinotecan hydr... leucovorin calc... mitomycin C oxaliplatin therapeutic con... | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy and Bevacizumab With or Without Bevacizumab Maintenance Therapy in Treating Patients With Metastatic Colorectal Cancer | NCT00952029 | Colorectal Canc... | bevacizumab FOLFIRI regimen fluorouracil irinotecan hydr... leucovorin calc... | 18 Years - 120 Years | Federation Francophone de Cancerologie Digestive | |
| wXELIRI Versus FOLFIRI Regimen in the Treatment of Advanced Colorectal Cancer Patients | NCT01736904 | Colorectal Canc... | wXELIRI regimen FOLFIRI regimen | 18 Years - 70 Years | Fudan University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
